Non-invasive Monitoring of Cancer Treatment with 19F MR Spectroscopy
Author Information
Author(s): Dresselaers T, Theys J, Nuyts S, Wouters B, de Bruijn E, Anné J, Lambin P, Van Hecke P, Landuyt W
Primary Institution: KU Leuven
Hypothesis
Can 19F MRS be used to non-invasively assess the conversion of 5-fluorocytosine to 5-fluorouracil in tumors using recombinant Salmonella?
Conclusion
The study demonstrates that 19F MRS can effectively monitor the production of 5-fluorouracil from 5-fluorocytosine in tumors treated with a recombinant bacteria therapy.
Supporting Evidence
- 19F MRS can detect the conversion of 5-fluorocytosine to 5-fluorouracil in tumors.
- The study used a mouse model to demonstrate the effectiveness of the treatment.
- Results showed that the production of 5-fluorouracil can be monitored over time.
- Attenuated Salmonella was used as a delivery vector for the therapy.
Takeaway
Scientists used a special imaging technique to see how a cancer treatment works inside tumors without needing to take samples. They found that the treatment was effective.
Methodology
The study involved using 19F MRS to monitor the conversion of 5-fluorocytosine to 5-fluorouracil in a mouse model with human tumors.
Limitations
The study primarily focused on a specific mouse model, which may not fully represent human responses.
Participant Demographics
Mice bearing HCT116 human colon tumors were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website